West Pharmaceutical Services ROA 2010-2023 | WST
Current and historical return on assets (ROA) values for West Pharmaceutical Services (WST) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| West Pharmaceutical Services ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2023-12-31 |
$0.59B |
$3.83B |
15.84% |
| 2023-09-30 |
$0.56B |
$3.76B |
15.14% |
| 2023-06-30 |
$0.52B |
$3.67B |
14.49% |
| 2023-03-31 |
$0.55B |
$3.72B |
15.78% |
| 2022-12-31 |
$0.59B |
$3.62B |
17.28% |
| 2022-09-30 |
$0.63B |
$3.32B |
19.02% |
| 2022-06-30 |
$0.69B |
$3.36B |
20.95% |
| 2022-03-31 |
$0.69B |
$3.30B |
21.60% |
| 2021-12-31 |
$0.66B |
$3.31B |
21.83% |
| 2021-09-30 |
$0.61B |
$3.14B |
21.08% |
| 2021-06-30 |
$0.52B |
$2.93B |
18.75% |
| 2021-03-31 |
$0.42B |
$2.74B |
16.06% |
| 2020-12-31 |
$0.35B |
$2.79B |
13.78% |
| 2020-09-30 |
$0.31B |
$2.58B |
13.01% |
| 2020-06-30 |
$0.29B |
$2.39B |
12.45% |
| 2020-03-31 |
$0.26B |
$2.25B |
11.71% |
| 2019-12-31 |
$0.24B |
$2.34B |
11.11% |
| 2019-09-30 |
$0.23B |
$2.17B |
11.02% |
| 2019-06-30 |
$0.23B |
$2.12B |
11.28% |
| 2019-03-31 |
$0.22B |
$2.04B |
11.13% |
| 2018-12-31 |
$0.21B |
$1.98B |
10.80% |
| 2018-09-30 |
$0.16B |
$1.95B |
8.21% |
| 2018-06-30 |
$0.15B |
$1.87B |
8.01% |
| 2018-03-31 |
$0.13B |
$1.87B |
7.14% |
| 2017-12-31 |
$0.15B |
$1.86B |
8.20% |
| 2017-09-30 |
$0.19B |
$1.93B |
10.52% |
| 2017-06-30 |
$0.18B |
$1.84B |
10.07% |
| 2017-03-31 |
$0.18B |
$1.73B |
10.62% |
| 2016-12-31 |
$0.14B |
$1.72B |
8.44% |
| 2016-09-30 |
$0.14B |
$1.74B |
8.11% |
| 2016-06-30 |
$0.10B |
$1.71B |
6.06% |
| 2016-03-31 |
$0.09B |
$1.67B |
5.08% |
| 2015-12-31 |
$0.10B |
$1.70B |
5.80% |
| 2015-09-30 |
$0.09B |
$1.67B |
5.70% |
| 2015-06-30 |
$0.12B |
$1.66B |
7.45% |
| 2015-03-31 |
$0.13B |
$1.60B |
8.01% |
| 2014-12-31 |
$0.13B |
$1.67B |
7.52% |
| 2014-09-30 |
$0.12B |
$1.67B |
7.10% |
| 2014-06-30 |
$0.12B |
$1.71B |
6.87% |
| 2014-03-31 |
$0.11B |
$1.71B |
6.49% |
| 2013-12-31 |
$0.11B |
$1.67B |
6.93% |
| 2013-09-30 |
$0.11B |
$1.67B |
6.85% |
| 2013-06-30 |
$0.10B |
$1.61B |
6.24% |
| 2013-03-31 |
$0.08B |
$1.58B |
5.48% |
| 2012-12-31 |
$0.08B |
$1.56B |
5.39% |
| 2012-09-30 |
$0.08B |
$1.53B |
5.41% |
| 2012-06-30 |
$0.08B |
$1.46B |
5.67% |
| 2012-03-31 |
$0.09B |
$1.46B |
6.00% |
| 2011-12-31 |
$0.08B |
$1.40B |
5.45% |
| 2011-09-30 |
$0.06B |
$1.40B |
4.60% |
| 2011-06-30 |
$0.06B |
$1.42B |
4.76% |
| 2011-03-31 |
$0.07B |
$1.37B |
5.09% |
| 2010-12-31 |
$0.07B |
$1.29B |
5.21% |
| 2010-09-30 |
$0.08B |
$1.30B |
6.34% |
| 2010-06-30 |
$0.08B |
$1.22B |
6.31% |
| 2010-03-31 |
$0.08B |
$1.25B |
6.15% |
| 2009-12-31 |
$0.07B |
$1.27B |
5.88% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$27.235B |
$2.950B |
|
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
|
